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Abstract 
Purpose: To evaluate the in vitro antiproliferative activity of the extracts of the three plants against a 
panel of human tumor cell lines representing the most common types of cancer in Jordan, viz, breast 
and colorectal and skin cancers.  
Methods: The methanol extracts of the aerial parts of the three plants  (Arbutus andrachne L., 
Chrysanthemum coronarium L., and Teucrium polium L.) were prepared and assessed for 
antiproliferative activity against six human tumor cell lines (A375.S2, WM1361A, CACO-2, HRT18, 
MCF-7, T47D) using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide  MTT  cell proliferation 
assay.  
Results: C. coronarium extract, at the concentration range of 25 to 400 µg/mL, significantly inhibited (10 
– 50 %) the proliferation of the 6 cell lines in a dose-dependent manner, whilst the extracts of the other 
two plants exhibited weak antiproliferative activity (2 – 10 % inhibition). The half-maximal inhibitory 
concentration (IC50) values of C. coronarium extract against the six cell lines were in the range of 75.8 to 
138.5 µg/mL.  
Conclusion: The methanol extract of the aerial parts C. coronarium possesses a relatively potent 
antiproliferative activity and therefore might be a potential source of natural compounds that can be 
developed into new antineoplastic agents. 
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Cancer is one of the leading causes of death 
worldwide. The global incidence of cancer is in 
continuous rise in concomitance with the 
presence of cancer therapy-related problems. 
The emergence of resistance, the high toxicity 
and the high cost of many anticancer agents are 
some of the reasons that limited their use in 
clinical settings [1]. Therefore, large bulk of 
research is now focused on finding new 
anticancer agents to address these issues. 
 
Screening plants for anticancer activity has been 
a historically important field of research that has 
resulted in the introduction of several anticancer 
drugs to the market. Some of these are vinca 
alkaloids (vinblastine and vincristine) that were 
isolated from Catharanthus roseus and taxol 
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(paclitaxel) that was isolated from Taxus 
brevifolia in the 1970s [2]. 
 
Plant-derived natural products are a potential 
source of cheap antineoplastic agents. Currently, 
this is of particular importance in developing 
countries where cancer-related economic burden 
is high [3]. Therefore, various research groups in 
these counties are investigating medicinal plants 
for cytotoxic activities [4-5]. 
 
In Jordan, one of the developing countries, 
cancer is the second leading cause of death after 
heart diseases, and the resources assigned for 
cancer treatment are limited [6]. Hence, 
searching for medicinal plants with antineoplastic 
activity is becoming popular among the scientific 
community in Jordan [7-9]. According to the 
cancer registry in Jordan, breast cancer is the 
most common type of cancer followed by 
colorectal carcinoma [6]. Therefore, it is 
important to find cheaper alternative to the 
conventional anticancer agents used for the 
treatment of these types of cancer. Skin cancer, 
for example, despite its low incidence in Jordan, 
is traditionally treated with topical herbal 
preparations as they provide a relatively safe and 
readily available choice of therapy for this type of 
cancer [6]. 
 
Arbutus andrachne L., Chrysanthemum 
coronarium L. and Teucrium polium L. are three 
medicinal plants from Jordan flora, and are of 
Mediterranean origin [10].These plants have 
been used in folk medicine for the management 
of a range of medical conditions including 
cancer, and have several reported 
pharmacological activities that are relevant to 
anticancer activity [11-12]. However, little is 
known about the antiproliferative effects of these 
plants on breast, colorectal and skin cancer.  
Consequently, the aim of the current study is to 
investigate the in vitro antiproliferative activity of 
these plants on human tumor cell lines 






Aerial parts of the plants under investigation 
(Arbutus andrachne L., Chrysanthemum 
coronarium L., and Teucrium polium L.) (see 
Table 1) were collected from Northern Jordan. 
Verification of the taxonomic identity of each 
plant was performed by Dr. Khaled Tawaha 
(Faculty of Pharmacy, Amman, Jordan) and 
voucher specimens of the plants were deposited 
there (Table 1). 
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The plant materials were air-dried under shade at 
room temperature (22 – 23 °C), and then 
separately homogenized into fine powder. The 
powdered materials were stored in airtight amber 
glass containers prior to extraction. Ten grams of 
the plant powder were soaked in 500 mL of 
methanol, in a shaking water bath, at 37 ºC 
(Labtech, Korea) for 5 days. The extract was 
then centrifuged at 1500 g for 10 min and the 
solvent in the recovered supernatant was 
evaporated under reduced pressure using a 
rotary evaporator (Heidolph Laborota, Germany). 
The solid residues were then dissolved in DMSO 
to prepare stock solutions and stored at -20 ºC 




Six solid human tumor cell lines (summarized in 
Table 2) were cultured in RPMI-1640 medium 
(Lonza) supplemented with 10 % fetal bovine 
serum (Gibco), 10 mM HEPES buffer (pH  7.3), 2 
mM L-glutamine, 50 µg/mL gentamicin, 100 
U/mL penicillin and 100 μg/mL streptomycin 
sulfate (all from Lonza). The cultures were 
maintained at 5 % CO2 in a humid environment 
at 37 ºC. Viable cell count was determined by 
trypan blue dye exclusion method. 
 
Cytotoxicity and MTT cell viability assays 
 
Cells in their log phase of growth were used to 
prepare the cultures in a flat-bottomed 96-well 
microplate. Based on optimization experiments, 
the two malignant melanoma cell lines were 
seeded at a final count of 4 x 104 cells/200 µl/well 
while the rest of the cell lines were seeded at a 
count of 2 x 104 cells/200 µl/well. Cultures were 
then incubated for 24 h before they were left 
untreated (complete growth media only) as a cell 
growth control, treated with 6.25, 12.5, 25, 50, 
100, 200, 400 µg/mL 400, 200, 100, 50, 25, 12.5 
or 6.25 µg/mL of the plant extracts (test 
samples), or treated with the corresponding final 
concentration of DMSO only (0.04, 0.08, 0.16, 
0.32, 0.65, 1.3, 2.6 %) as a solvent control. For 
the screening test, cultures were treated with 100 
µg/mL of the plant extract or 0.65 % of DMSO as 
described above. Each treatment group was 
prepared in triplicate wells. Cultures were then 
incubated for another 72 h before measurement 
of cell viability using MTT (3-(4, 5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide) assay (sigma). Twenty microliters of 5 
mg/mL MTT solution in PBS were added to each 
well and incubated for 3 h at 37 ⁰C to allow the 
formation of the purple formazin crystals within 
the viable cells. The supernatants were 
discarded and the crystals were then left to 
dissolve in 200 µL of DMSO for 10 min at 37 ⁰C, 
giving a purple-colored solution of formazin. 
Absorbance was measured at 570 nm using a 
microplate reader (BioteK, USA). Cell viability 
(Cv, %) was determined as in Eq 1.  
 
Cv (%) = (At/Ac)100 ………………………… (1) 
 
where At and Ac are the absorbance of the test 
sample and control (blank solvent), respectively. 
 
IC50, defined as the concentration at which 50 % 




Data are expressed as mean ± standard 
deviation SD (n = 3). Statistical analysis was with 
Prism 5 software (GraphPad, USA) by one-way 
ANOVA. Differences were considered significant 






As shown in Table 3, C. coronarium consistently 
reduced cell viability in all the cell lines, to 
varying extent, except CACO-II cells. In contrast, 
both A. andrachne and T. polium did not exhibit 
antiproliferative activity against any of the cell 
lines except for A375.S2 malignant melanoma 
cell line (~40 and 60 % inhibition, respectively), 
which is attributed to the variable responsiveness 
of the different cell lines. C. coronarium was 
therefore considered to have a potential 
antiproliferative effect compared to the other two 
plants. 
 
        Table 2: Cell lines used in this study 
 
Cell type Cell line Description 
Epithelial-like  MCF-7 Breast adenocarcinoma 
Epithelial  T47D ductal epithelial breast tumor 
Epithelial  CACO-2 Colorectal adenocarcinoma 
Epithelial  HRT18 Rectum adenocarcinoma 
Epithelial-like A375.S2 Malignant melanoma 
Melanocyte  WM1361A Malignant melanoma 
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Table 3: Cell viability of six tumor cell lines after treatment with 100 µg/mL of the methanol extract of the 
investigated plants for 72 h 
 







MCF-7 97.79 ± 6.45 91.45 ± 2.33 118.5 ± 11.28 
T47D 108.8 ± 33.44 22.62 ± 12.23 98.5 ± 2.99 
CACO-2 121.2 ± 3.00 94.75 ± 3.12 102.2 ± 1.82 
HRT18 90.1 ± 6.3 44.37 ± 3.39 89.78 ± 7.44 
A375.S2 40.56 ± 5.99 79.83 ± 2.63 61.1 ± 4.46 
WM1361A 115.5 ± 2.96 70.97 ± 3.19 99.64 ± 3.53 
         Data are presented as mean ± SD (n = 3) 
 
 
Figure 1: In vitro antiproliferative activity of the methanol extract of C. coronarium against 6 tumor cell lines. 
Cells were left untreated, treated with various concentrations of C. coronarium extract (6.25, 12.5, 25, 50, 100, 
200 or 400 µg/mL), or treated with the corresponding concentration of DMSO as a solvent control. Cultures were 
left for 72 hours before determination of cell viability using MTT assay. (a) Cell viability of two human breast 
tumor cell lines. (b) Cell viability of two human rectal tumor cell lines. (c) Cell viability of two human malignant 
melanoma cell lines. Data are presented as normalized mean values ± SD (n = 3). *, p < 0.05; **, p < 0.01; ***, p 
< 0.001 
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In Jordan, the search for medicinal plants with 
antitumor activity is becoming popular. This is in 
keeping with the increasing demand for a 
relatively cheaper and safer substitute to the 
established anticancer agents. To our 
knowledge, little evidence is known about the 
antiproliferative effect of A. andrachne, C. 
coronarium and T. polium, in spite of their use in 
traditional medicine for cancer treatment. In the 
present study, there is evidence of the 
antiproliferative activity of C. coronarium extract 
against three types of human tumor cell lines 
(breast cancer, colorectal cancer and skin 
cancer). However, the methanolic extract of A. 
andrachne and T. polium did not exhibit 
significant effects (except for A375.S2 cell line) at 
the concentration used. 
 
Based on the screening test, C. coronarium 
extract consistently inhibited the proliferation of 
the six cell lines at 100 µg/mL. Variable degrees 
of antiproliferative activity was achieved against 
the different cell lines. The highest activity was 
demonstrated against malignant melanoma cell 
line (WM1361A) and ductal epithelial breast 
tumor cell line (T47D) with IC50 of 75.7 and 79.8 
µg/mL, respectively. Whilst MCF-7 breast 
carcinoma cell line was least sensitive (IC50 = 
138.5 µg/mL). In addition to the antiproliferative 
activity of the plant extract we show here, several 
previous reports demonstrated multiple 
pharmacological activities of C. coronarium 
extracts that support its potential anticancer 
activity. Choi et al had demonstrated anti-
angiogenic effect of campesterol, a phytosterol 
isolated from C. coronarium, which inhibited 
fibroblast growth factor-mediated endothelial cell 
proliferation in vitro [11]. In addition, C. 
coronarium extract resulted in the activation of 
type-1 immunity in vitro through induction of IFN-
γ production by murine natural killer cells in vitro 
[12]. Considering the volatile oil extract of C. 
coronarium, Marongiu et al had demonstrated 
cytotoxic activity of this extract against Hela and 
Vero cells [14]. Therefore, C. coronarium might 
be of a promising therapeutic value in the 
treatment of cancer. This, however, requires 
further investigation of the anticancer activity of 
some known chemical constituents of the plant 
such as quinic acid derivatives and 
sesquiterpene lactones [18]. 
 
In literature, few species of the genus 
Chrysanthemum are reported to have anticancer 
activity. C. morifolium, for example, was reported 
to exhibit anti-mutagenic activity due to its 
flavonoids contents [19], while, cytotoxic activity 
was observed for C. segetum and C. flosculosus 
[14]. 
 
With respect to the antiproliferative activity of T. 
polium and A. andrachne, the methanolic 
extracts of both plants exhibited weak 
antiproliferative effect against the tumor cell lines 
(at 100 µg/mL). This is in keeping with the results 
obtained by another study in Jordan, which 
showed only a relatively weak antiproliferative 
effect of the ethanolic extracts of either plants [7]. 
However, considering T. polium, other studies in 
Iran demonstrated an in vitro cytotoxic effect of 
the  methanol and the ethanol extracts of this 
plant against a range of human tumor cell lines 
(Skmel-3, Saos-2, SW480, MCF-7, KB, EJ and 
A431,  A549, BT20, and PC12) [20]. Besides, the 
essential oils of T. polium ssp. capitatum (from 
Greece) exhibited in vitro antiproliferative effect 
against CACO-2 cell line [34]. This discrepancy 
might be attributed to the possible chemical 
polymorphism (chemotypes) among T. polium 
plants growing in different countries, and to the 
possible variable responses of the different tumor 




The data obtained in this study suggest that the 
methanol extract of C. coronarium has potential 
antiproliferative activity against several human 
tumor cell lines. This new insight into the 
anticancer activity of this plant positions it as a 
source of lead compounds which are promising 
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